 | • レポートコード：GIR201101328 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、体軸性脊椎関節炎治療薬の世界市場を調査対象にし、体軸性脊椎関節炎治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（セルトリズマブペゴル、エタネルセプトバイオシミラー、イキセキズマブ、セクキヌマブ、その他）、用途別分析（クリニック、病院、在宅医療）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AstraZeneca Plc、UCB SA、Novartis AG、Eli Lilly and Company、Sun Pharma Advanced Research Company Ltd、Johnson & Johnson、Sandoz International GmbH、Panacea Biotec Ltd ・メーカー別販売量、売上、市場シェア ・体軸性脊椎関節炎治療薬の地域別市場分析 ・体軸性脊椎関節炎治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・体軸性脊椎関節炎治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・体軸性脊椎関節炎治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・体軸性脊椎関節炎治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・体軸性脊椎関節炎治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・体軸性脊椎関節炎治療薬の種類別市場規模2015-2020：セルトリズマブペゴル、エタネルセプトバイオシミラー、イキセキズマブ、セクキヌマブ、その他 ・体軸性脊椎関節炎治療薬の用途別市場規模2015-2020：クリニック、病院、在宅医療 ・体軸性脊椎関節炎治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Axial Spondyloarthritis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Axial Spondyloarthritis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Axial Spondyloarthritis Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Axial Spondyloarthritis Drugs market has been segmented into
Certolizumab Pegol
Etanercept Biosimilar
Ixekizumab
Secukinumab
Others
By Application, Axial Spondyloarthritis Drugs has been segmented into:
Clinic
Hospital
Home Care
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Axial Spondyloarthritis Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Axial Spondyloarthritis Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Axial Spondyloarthritis Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Axial Spondyloarthritis Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Axial Spondyloarthritis Drugs Market Share Analysis
Axial Spondyloarthritis Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Axial Spondyloarthritis Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Axial Spondyloarthritis Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Axial Spondyloarthritis Drugs are:
AstraZeneca Plc
UCB SA
Novartis AG
Eli Lilly and Company
Sun Pharma Advanced Research Company Ltd
Johnson & Johnson
Sandoz International GmbH
Panacea Biotec Ltd
Among other players domestic and global, Axial Spondyloarthritis Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Axial Spondyloarthritis Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Axial Spondyloarthritis Drugs, with price, sales, revenue and global market share of Axial Spondyloarthritis Drugs in 2018 and 2019.
Chapter 3, the Axial Spondyloarthritis Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Axial Spondyloarthritis Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Axial Spondyloarthritis Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Axial Spondyloarthritis Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Axial Spondyloarthritis Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Axial Spondyloarthritis Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Certolizumab Pegol
1.2.3 Etanercept Biosimilar
1.2.4 Ixekizumab
1.2.5 Secukinumab
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Axial Spondyloarthritis Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Care
1.4 Overview of Global Axial Spondyloarthritis Drugs Market
1.4.1 Global Axial Spondyloarthritis Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca Plc SWOT Analysis
2.1.4 AstraZeneca Plc Product and Services
2.1.5 AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 UCB SA
2.2.1 UCB SA Details
2.2.2 UCB SA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 UCB SA SWOT Analysis
2.2.4 UCB SA Product and Services
2.2.5 UCB SA Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly and Company SWOT Analysis
2.4.4 Eli Lilly and Company Product and Services
2.4.5 Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sun Pharma Advanced Research Company Ltd
2.5.1 Sun Pharma Advanced Research Company Ltd Details
2.5.2 Sun Pharma Advanced Research Company Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sun Pharma Advanced Research Company Ltd SWOT Analysis
2.5.4 Sun Pharma Advanced Research Company Ltd Product and Services
2.5.5 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sandoz International GmbH
2.7.1 Sandoz International GmbH Details
2.7.2 Sandoz International GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sandoz International GmbH SWOT Analysis
2.7.4 Sandoz International GmbH Product and Services
2.7.5 Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Panacea Biotec Ltd
2.8.1 Panacea Biotec Ltd Details
2.8.2 Panacea Biotec Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Panacea Biotec Ltd SWOT Analysis
2.8.4 Panacea Biotec Ltd Product and Services
2.8.5 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Axial Spondyloarthritis Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Axial Spondyloarthritis Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Axial Spondyloarthritis Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Axial Spondyloarthritis Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Axial Spondyloarthritis Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Axial Spondyloarthritis Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
4.5 South America Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Axial Spondyloarthritis Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Axial Spondyloarthritis Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Axial Spondyloarthritis Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Axial Spondyloarthritis Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
6.3 UK Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
6.4 France Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Axial Spondyloarthritis Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Axial Spondyloarthritis Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
7.5 India Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Axial Spondyloarthritis Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Axial Spondyloarthritis Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Axial Spondyloarthritis Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Axial Spondyloarthritis Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Axial Spondyloarthritis Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Axial Spondyloarthritis Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Axial Spondyloarthritis Drugs Price by Type (2015-2020)
11 Global Axial Spondyloarthritis Drugs Market Segment by Application
11.1 Global Axial Spondyloarthritis Drugs Sales Market Share by Application (2015-2020)
11.2 Global Axial Spondyloarthritis Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Axial Spondyloarthritis Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Axial Spondyloarthritis Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Axial Spondyloarthritis Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Axial Spondyloarthritis Drugs Market Forecast (2021-2025)
12.2.2 Europe Axial Spondyloarthritis Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Axial Spondyloarthritis Drugs Market Forecast (2021-2025)
12.2.4 South America Axial Spondyloarthritis Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Axial Spondyloarthritis Drugs Market Forecast (2021-2025)
12.3 Axial Spondyloarthritis Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Axial Spondyloarthritis Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Axial Spondyloarthritis Drugs Market Share Forecast by Type (2021-2025)
12.4 Axial Spondyloarthritis Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Axial Spondyloarthritis Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Axial Spondyloarthritis Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Axial Spondyloarthritis Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Axial Spondyloarthritis Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Axial Spondyloarthritis Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc Axial Spondyloarthritis Drugs Major Business
Table 9. AstraZeneca Plc Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2018-2019)
Table 10. AstraZeneca Plc SWOT Analysis
Table 11. AstraZeneca Plc Axial Spondyloarthritis Drugs Product and Services
Table 12. AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. UCB SA Basic Information, Manufacturing Base and Competitors
Table 14. UCB SA Axial Spondyloarthritis Drugs Major Business
Table 15. UCB SA Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2018-2019)
Table 16. UCB SA SWOT Analysis
Table 17. UCB SA Axial Spondyloarthritis Drugs Product and Services
Table 18. UCB SA Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis AG Axial Spondyloarthritis Drugs Major Business
Table 21. Novartis AG Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Novartis AG SWOT Analysis
Table 23. Novartis AG Axial Spondyloarthritis Drugs Product and Services
Table 24. Novartis AG Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly and Company Axial Spondyloarthritis Drugs Major Business
Table 27. Eli Lilly and Company Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Eli Lilly and Company SWOT Analysis
Table 29. Eli Lilly and Company Axial Spondyloarthritis Drugs Product and Services
Table 30. Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sun Pharma Advanced Research Company Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Major Business
Table 33. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Sun Pharma Advanced Research Company Ltd SWOT Analysis
Table 35. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product and Services
Table 36. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson & Johnson Axial Spondyloarthritis Drugs Major Business
Table 39. Johnson & Johnson Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Johnson & Johnson SWOT Analysis
Table 41. Johnson & Johnson Axial Spondyloarthritis Drugs Product and Services
Table 42. Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sandoz International GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz International GmbH Axial Spondyloarthritis Drugs Major Business
Table 45. Sandoz International GmbH Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Sandoz International GmbH SWOT Analysis
Table 47. Sandoz International GmbH Axial Spondyloarthritis Drugs Product and Services
Table 48. Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 50. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Major Business
Table 51. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2018-2019)
Table 52. Panacea Biotec Ltd SWOT Analysis
Table 53. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product and Services
Table 54. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Axial Spondyloarthritis Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 56. Global Axial Spondyloarthritis Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Axial Spondyloarthritis Drugs Sales by Regions (2015-2020) (K Pcs)
Table 58. Global Axial Spondyloarthritis Drugs Sales Market Share by Regions (2015-2020)
Table 59. Global Axial Spondyloarthritis Drugs Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Axial Spondyloarthritis Drugs Sales by Countries (2015-2020) (K Pcs)
Table 61. North America Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020)
Table 62. North America Axial Spondyloarthritis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020)
Table 64. Europe Axial Spondyloarthritis Drugs Sales by Countries (2015-2020) (K Pcs)
Table 65. Europe Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020)
Table 66. Europe Axial Spondyloarthritis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Axial Spondyloarthritis Drugs Sales by Regions (2015-2020) (K Pcs)
Table 68. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Axial Spondyloarthritis Drugs Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Axial Spondyloarthritis Drugs Sales by Countries (2015-2020) (K Pcs)
Table 71. South America Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020)
Table 72. South America Axial Spondyloarthritis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Axial Spondyloarthritis Drugs Sales by Countries (2015-2020) (K Pcs)
Table 75. Middle East & Africa Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Axial Spondyloarthritis Drugs Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020)
Table 78. Global Axial Spondyloarthritis Drugs Sales by Type (2015-2020) (K Pcs)
Table 79. Global Axial Spondyloarthritis Drugs Sales Share by Type (2015-2020)
Table 80. Global Axial Spondyloarthritis Drugs Revenue by Type (2015-2020) (USD Million)
Table 81. Global Axial Spondyloarthritis Drugs Revenue Share by Type (2015-2020)
Table 82. Global Axial Spondyloarthritis Drugs Sales by Application (2015-2020) (K Pcs)
Table 83. Global Axial Spondyloarthritis Drugs Sales Share by Application (2015-2020)
Table 84. Global Axial Spondyloarthritis Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 85. Global Axial Spondyloarthritis Drugs Market Share Forecast by Regions (2021-2025)
Table 86. Global Axial Spondyloarthritis Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 87. Global Axial Spondyloarthritis Drugs Market Share Forecast by Type (2021-2025)
Table 88. Global Axial Spondyloarthritis Drugs Sales Forecast by Application (2021-2025)
Table 89. Global Axial Spondyloarthritis Drugs Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Axial Spondyloarthritis Drugs Picture
Figure 2. Global Sales Market Share of Axial Spondyloarthritis Drugs by Type in 2019
Figure 3. Certolizumab Pegol Picture
Figure 4. Etanercept Biosimilar Picture
Figure 5. Ixekizumab Picture
Figure 6. Secukinumab Picture
Figure 7. Others Picture
Figure 8. Axial Spondyloarthritis Drugs Sales Market Share by Application in 2018
Figure 9. Clinic Picture
Figure 10. Hospital Picture
Figure 11. Home Care Picture
Figure 12. Global Axial Spondyloarthritis Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Axial Spondyloarthritis Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Axial Spondyloarthritis Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Axial Spondyloarthritis Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Axial Spondyloarthritis Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Axial Spondyloarthritis Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Axial Spondyloarthritis Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Axial Spondyloarthritis Drugs Sales Market Share by Countries in 2018
Figure 49. North America Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Axial Spondyloarthritis Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Axial Spondyloarthritis Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Axial Spondyloarthritis Drugs Revenue Market Share by Regions 2019
Figure 65. China Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Axial Spondyloarthritis Drugs Sales Market Share by Countries in 2019
Figure 72. South America Axial Spondyloarthritis Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Axial Spondyloarthritis Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Axial Spondyloarthritis Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Axial Spondyloarthritis Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Axial Spondyloarthritis Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
エクセナチド薬の世界市場 2020年 Market Overview The global Exenatide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Exenatide Drugs market report…- 軸流圧縮機の世界市場 2020年 Market Overview The Axial Flow Compressors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- テデュグルチド薬の世界市場 2020年 Market Overview The global Teduglutide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Teduglutide Drugs market re…
- メニエール病治療薬の世界市場 2020年 Market Overview The global Meniere Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere Disease Drugs m…
- アキシャルピストン油圧モーターの世界市場 2020年 Market Overview The Axial Piston Hydraulic Motor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…